Empaa M XR 12.5/1000mg tablet

Empaa M XR 12.5/1000mg tablet is a combination medication containing Empagliflozin and Metformin. It is used in the management of type 2 diabetes mellitus to help control blood sugar levels. Empagliflozin belongs to a class of medications called sodium-glucose cotransporter 2 (SGLT2) inhibitors, while Metformin is a biguanide antidiabetic agent. This combination works by helping the kidneys remove glucose from the bloodstream through urine, thereby lowering blood sugar levels. It also helps to improve insulin sensitivity and reduce hepatic glucose production.

Key Features:

• Dual Mechanism of Action: Empagliflozin inhibits the reabsorption of glucose by the kidneys, leading to increased urinary glucose excretion, while Metformin improves insulin sensitivity and reduces hepatic glucose production.
• Blood Sugar Control: Empaa M XR 12.5/1000mg tablet helps to lower blood sugar levels in patients with type 2 diabetes mellitus, thereby reducing the risk of diabetes-related complications.
• Once-Daily Formulation: Empaa M XR 12.5/1000mg tablet is formulated for extended-release, allowing for once-daily dosing convenience and improved patient adherence to treatment.

Uses:

Empaa M XR 12.5/1000mg tablet is indicated for:

• Management of Type 2 Diabetes Mellitus: Treatment of adults with type 2 diabetes mellitus to improve glycemic control as an adjunct to diet and exercise.

Directions for Use:

• Take Empaa M XR 12.5/1000mg tablet orally once daily with the morning meal or as directed by your healthcare provider.
• Swallow the tablet whole with a glass of water; do not crush, chew, or break the tablet.
• It is essential to follow the prescribed dosage and regimen as directed by your healthcare provider for optimal blood sugar control.
• Regular monitoring of blood sugar levels and periodic evaluation by your healthcare provider are recommended during treatment with Empaa M XR 12.5/1000mg tablet.

Precautions:

• Inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking before starting Empaa M XR 12.5/1000mg tablet.
• Use caution in patients with renal impairment or history of ketoacidosis, as Empagliflozin may increase the risk of these conditions.
• Monitor kidney function regularly during treatment with Empaa M XR 12.5/1000mg tablet, as both Empagliflozin and Metformin may affect renal function.
• Avoid excessive alcohol consumption while taking Empaa M XR 12.5/1000mg tablet, as it may increase the risk of lactic acidosis.

Frequently Asked Questions (FAQs):

1. What should I do if I miss a dose of Empaa M XR 12.5/1000mg tablet? If you miss a dose of Empaa M XR 12.5/1000mg tablet, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for the missed one.
2. Can Empaa M XR 12.5/1000mg tablet cause side effects? Common side effects of Empaa M XR 12.5/1000mg tablet may include urinary tract infections, genital yeast infections, increased urination, and dehydration. Inform your healthcare provider if you experience any persistent or bothersome side effects.
3. Is Empaa M XR 12.5/1000mg tablet suitable for use in children? Empaa M XR 12.5/1000mg tablet is not recommended for use in children under 18 years of age, as its safety and efficacy have not been established in this population. It is intended for use in adults with type 2 diabetes mellitus.
4. Can Empaa M XR 12.5/1000mg tablet be used during pregnancy or breastfeeding? Empaa M XR 12.5/1000mg tablet should not be used during pregnancy or breastfeeding unless prescribed by a healthcare provider. It is essential to discuss the potential risks and benefits with your healthcare provider before using this medication during pregnancy or lactation.
5. Are there any drug interactions with Empaa M XR 12.5/1000mg tablet? Empaa M XR 12.5/1000mg tablet may interact with certain medications, including other antidiabetic agents, diuretics, corticosteroids, and certain medications affecting renal function. Inform your healthcare provider about all medications you are currently taking to avoid potential interactions.